title: Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain.
abstract: In addition to their major function in antigen presentation and natural killer cell activity regulation, HLA class I molecules may modulate T-cell activation and proliferation. Monoclonal antibodies (MoAbs) that recognize distinct epitopes of HLA class I molecules were reported to interfere with T-cell proliferation. We show here that two MoAbs (mouse MoAb90 and rat YTH862) that bind to an epitope of the alpha1 domain of HLA class I heavy chain induce apoptotic cell death of activated, but not resting, peripheral T lymphocytes. Other reference anti-HLA class I antibodies specific for distinct epitopes of the alpha1 (B9.12.1), alpha2 (W6/32), or alpha3 (TP25.99) domains of the heavy chain decreased T-cell proliferation but had little or no apoptotic effect. Apoptosis shown by DNA fragmentation, phosphatidylserine externalization, and decrease of mitochondrial transmembrane potential was observed whatever the type of T-cell activator. Apoptosis did not result from Fas/Fas-L interaction and distinct though partly overlapping populations of activated T cells were susceptible to Fas- and HLA class I-mediated apoptosis, respectively. Induction of apoptosis did not require HLA class I cross-linking inasmuch as it could be observed with monovalent Fab' fragments. The data indicate that MoAb90 and YTH862 directed against the alpha1 domain of HLA class I trigger apoptosis of activated T lymphocytes by a pathway which does not involve Fas-ligand.
authors.affiliation: Laboratory of Immunology, INSERM U80 UCBL, Hôpital E. Herriot, Lyon, France.
authors.forename: L
authors.initials: L
authors.lastname: Genestier
authors.forename: R
authors.initials: R
authors.lastname: Paillot
authors.forename: N
authors.initials: N
authors.lastname: Bonnefoy-Berard
authors.forename: G
authors.initials: G
authors.lastname: Meffre
authors.forename: M
authors.initials: M
authors.lastname: Flacher
authors.forename: D
authors.initials: D
authors.lastname: Fèvre
authors.forename: Y J
authors.initials: YJ
authors.lastname: Liu
authors.forename: P
authors.initials: P
authors.lastname: Le Bouteiller
authors.forename: H
authors.initials: H
authors.lastname: Waldmann
authors.forename: V H
authors.initials: VH
authors.lastname: Engelhard
authors.forename: J
authors.initials: J
authors.lastname: Banchereau
authors.forename: J P
authors.initials: JP
authors.lastname: Revillard
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000276:immunology*; D002478:Cells, Cultured; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D051381:Rats; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology*; D019014:fas Receptor / Q000276:immunology*
chemical_list: D000906:Antibodies; D015395:Histocompatibility Antigens Class I; D019014:fas Receptor